Destruction of alveolar walls and septa removes part of the lung’s normal elastic recoil, the restoring force that helps the lungs return toward their resting size. As recoil declines, respiratory mechanics become less effective and airflow limitation can contribute to breathlessness. This links the microscopic structural injury directly to impaired respiratory function in obstructive lung disease.
When septa are destroyed, neighboring distal airspaces can merge into larger spaces. The resulting architecture provides less surface area for gas exchange than the original arrangement of intact airspaces. This structural loss helps explain why airspace enlargement is clinically important: it is not merely a change in size, but a change that can compromise the lung’s ability to support normal respiratory function.
Pathological enlargement is interpreted as a sign of structural injury rather than accepted as normal variation. Evidence that alveolar walls or septa have been destroyed supports the abnormal interpretation, especially when the finding occurs with obstructive lung disease or related respiratory symptoms. This distinction prevents an enlarged air-containing space from being considered significant solely because of its appearance.
Histological examination can demonstrate the tissue changes underlying the enlarged spaces, particularly destruction of alveolar walls and septa and the merging of neighboring spaces. That microscopic evidence helps connect an observed structural pattern with loss of recoil and reduced gas-exchange surface area. It also provides a basis for studying how chronic lung injury produces functional respiratory impairment.
Chest imaging helps clinicians recognize the pattern of enlarged air-containing spaces within the lungs and place it in a broader assessment of obstructive lung disease. The finding can then be considered alongside symptoms and other clinical information to evaluate disease progression. Comparing assessments over time may also help evaluate whether treatment response is associated with structural change.
Recognizing this pattern can help explain symptoms such as breathlessness by showing a structural basis for impaired respiratory function. It may also support assessment of obstructive lung disease, disease progression, and treatment response. In medical research, the same finding provides a way to relate chronic lung injury to changes in lung architecture and respiratory performance.